NEWS RELEASE September 2017
Pharmaceutical Membrane Cartridge Market to Exceed $1.2 billion Next Year
Membrane cartridges are used in separation processes in the pharmaceutical industry. They are also used to purify water for use in products. A third use is the removal of contaminants from wastewater. According to the latest forecast in Cartridge Filters: World Market the pharmaceutical industry will spend $1.2 billion on cartridges in 2018.
$ millions
World Region | 2018 |
Total | 1,198 |
Africa | 13 |
CIS | 7 |
East Asia | 308 |
Eastern Europe | 15 |
Middle East | 33 |
NAFTA | 418 |
South & Central America | 53 |
West Asia | 47 |
Western Europe | 304 |
NAFTA will continue to be the leading consumer although East Asia is showing the most quantitative growth. West Asia and specifically India is showing the largest percentage growth.
Membrane cartridges are in the high-performance category. This means that they are purchased more based on performance and less on price. As a result, a few thousand people at end users, EPCs, and system supplier companies are making most of the purchase decisions. The top three pharmaceutical companies are spending more than $130 million/yr for these cartridges.
Ranking | Company |
2020 Membrane Cartridge Purchases $ millions |
Market Share % |
1 | Pfizer | 49 | 4.40 |
2 | Merck | 34 | 3.00 |
3 | Roche | 37 | 3.29 |
4 | Sanofi | 33 | 2.99 |
5 | Johnson & Johnson | 31 | 2.79 |
6 | Novartis | 30 | 2.71 |
7 | AbbVie | 24 | 2.14 |
8 | Gilead | 23 | 2.04 |
9 | AstraZeneca | 22 | 1.92 |
10 | Amgen | 22 | 1.92 |
11 | GlaxoSmithKline | 21 | 1.88 |
12 | Takeda | 19 | 1.70 |
13 | Teva | 17 | 1.53 |
This report provides forecasts for 80 countries in each industry for four types of cartridges. It also provides estimated purchases by 550 end users and 400 EPC’s, and system suppliers.
For more information click on N024 Cartridge Filters: World Market
Bob Mcilvaine can answer questions and can be reached at This email address is being protected from spambots. You need JavaScript enabled to view it. 847 784 0012 ext. 112